Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02616133 · ClinicalTrials.gov registry record
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 30
- Enrollment target
NCT02616133 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 30 participants.
The verdict
NCT02616133 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Currently many patients with HER2+ Breast Cancer do not have the opportunity to be evaluated by a medical oncologist for neo-adjuvant treatment due to the current lack of care coordination between the surgeon/surgical oncologist and the medical oncologists. This project will evaluate the feasibility to enhance knowledge that drives adoption of evidence based care, and evaluate the improvement in care coordination between oncologists and surgeons for patients with HER2+ Breast Cancer in the Neo-Adjuvant setting.
Interventions
- OTHER chart abstraction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02616133
The ClinicalTrials.gov registry entry for NCT02616133 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which chart abstraction is the first listed.
NCT02616133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02616133 about?
NCT02616133 is a clinical study titled "HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program". Currently many patients with HER2+ Breast Cancer do not have the opportunity to be evaluated by a medical oncologist for neo-adjuvant treatment due to the current lack of care coordination between the surgeon/surgical oncologist and the medical oncologists. This project will evaluate the feasibilit...
What is the current status of trial NCT02616133?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2016-01. Estimated completion is 2017-03-31.
What interventions are being tested in trial NCT02616133?
The interventions under investigation include: chart abstraction (OTHER).
Who is sponsoring clinical trial NCT02616133?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.